Biblio

2024
Chen Y, Qiang Y, Fan J, Zheng Q, Yan L, Fan G, Song X, Zhang N, Lv Q, Xiong J, et al. Aggresome formation promotes ASK1/JNK signaling activation and stemness maintenance in ovarian cancer. Nat Commun. 2024;15(1):1321.
Imataki O, Uemura M. Aggressive progressive pleuroparenchymal fibroelastosis developed long after allogenic hematopoietic stem cell transplantation. Clin Case Rep. 2024;12(1):e8415.
Ong SYeu, Zain JM. Aggressive T-cell lymphomas: 2024: Updates on diagnosis, risk stratification, and management. Am J Hematol. 2024.
Prišlin M, Butorac A, Bertoša R, Kunić V, Ljolje I, Kostešić P, Vlahović D, Naletilić Š, Turk N, Brnić D. aging alters the gene expression and secretome composition of canine adipose-derived mesenchymal stem cells. Front Vet Sci. 2024;11:1387174.
Müller L, Di Benedetto S. Aging brain: exploring the interplay between bone marrow aging, immunosenescence, and neuroinflammation. Front Immunol. 2024;15:1393324.
Hossain MKamal, Kim H-R, Chae HJung. Aging Phenotype in AD Brain Organoids: Track to Success and Challenges. Ageing Res Rev. 2024:102256.
Tsuchiya Y, Seki T, Nakano H, Tanaka M, Takahashi R. [Aging-associated Cyst Formation and Fibrosis]. Yakugaku Zasshi. 2024;144(4):397-402.
Mueller JL, Stavely R, Guyer RA, Soos Á, Bhave S, Han C, Hotta R, Nagy N, Goldstein AM. Agrin Inhibition in Enteric Neural Stem Cells Enhances Their Migration Following Colonic Transplantation. Stem Cells Transl Med. 2024.
Maramraju S, Kowalczewski A, Kaza A, Liu X, Singaraju JPranav, Albert MV, Ma Z, Yang H. AI-organoid integrated systems for biomedical studies and applications. Bioeng Transl Med. 2024;9(2):e10641.
Zhang L, Kelly N, Shontz KM, Hill CL, Stack JT, Calyeca J, Matrka L, Miller A, Reynolds SD, Chiang T. Airway disease decreases the therapeutic potential of epithelial stem cells. Respir Res. 2024;25(1):28.
Peña-Cearra A, Palacios A, Pellon A, Castelo J, Pasco STanner, Seoane I, Barriales D, Martin JEzequiel, Pascual-Itoiz MÁngel, Gonzalez-Lopez M, et al. Akkermansia muciniphila-induced trained immune phenotype increases bacterial intracellular survival and attenuates inflammation. Commun Biol. 2024;7(1):192.
Odabas GPelin, Aslan K, Suna PAlisan, Kendirli PKader, Erdem S, Cakir M, Ozcan A, Yilmaz E, Karakukcu M, Donmez-Altuntas H, et al. Alantolactone ameliorates graft versus host disease in mice. Int Immunopharmacol. 2024;128:111560.
Schneider M, Potthoff A-L, Karpel-Massler G, Schuss P, Siegelin MD, Debatin K-M, Duffau H, Vatter H, Herrlinger U, Westhoff M-A. The Alcatraz-Strategy: a roadmap to break the connectivity barrier in malignant brain tumours. Mol Oncol. 2024.
Del Vecchio V, La Noce M, Tirino V. ALDH Activity Assay: A Method for Cancer Stem Cell (CSC) Identification and Isolation. Methods Mol Biol. 2024;2777:83-89.
Huang M, Fang W, Farrel A, Li L, Chronopoulos A, Nasholm N, Cheng B, Zheng T, Yoda H, Barata MJ, et al. ALK upregulates POSTN and WNT signaling to drive neuroblastoma. Cell Rep. 2024;43(3):113927.
Hayward B, Kumari D, van Karnebeek CDM, van Kuilenburg ABP, Usdin K. All three MutL complexes are required for repeat expansion in a human stem cell model of CAG-repeat expansion mediated glutaminase deficiency. bioRxiv. 2024.
Attia SHassan, Saadawy SF, El-Mahroky SM, Nageeb MM. Alleviation of pulmonary fibrosis by the dual PPAR agonist saroglitazar and breast milk mesenchymal stem cells via modulating TGFß/SMAD pathway. Naunyn Schmiedebergs Arch Pharmacol. 2024.
Riyadi SAmalia, Naini AArofatus, Mayanti T, Lesmana R, Azmi MNurul, Fajriah S, Jungsuttiwong S, Supratman U. Alliaxylines A-E: five new mexicanolides from the stem barks of Dysoxylum alliaceum (Blume) Blume ex A.Juss. J Nat Med. 2024.
Saha A, Palchaudhuri R, Lanieri L, Hyzy S, Riddle MJ, Panthera J, Eide C, Tolar J, Panoskaltsis-Mortari A, Gorfinkel L, et al. Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate conditioned Fanconi anemia mice. Blood. 2024.
Çam SBurak, Ciftci E, Gürbüz N, Altun B, Korkusuz P. Allogeneic bone marrow mesenchymal stem cell-derived exosomes alleviate human hypoxic AKI-on-a-Chip within a tight treatment window. Stem Cell Res Ther. 2024;15(1):105.
Maffini E, Labopin M, Kröger N, Finke J, Stelljes M, Schroeder T, Einsele H, Tischer J, Bornhäuser M, Bethge W, et al. Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2024.
Grunebaum E, Arnold DE, Logan B, Parikh S, Marsh RA, Griffith LM, Mallhi K, Chellapandian D, Lim SSi, Deal CL, et al. Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: a PIDTC study. J Allergy Clin Immunol. 2024.
da Silva PCristina L, Muzzi GCampos, Vilela MRibeiro, Fabreti-Oliveira RA. Allogeneic hematopoietic stem cell transplantation: A single-center experience, 2017 to 2021. Transpl Immunol. 2024:101989.
Riedel A, Faul C, Reuss K, Schröder J, Lang P, Lengerke C, Weissert N, Hengel H, Gröschel S, Schoels L, et al. Allogeneic Hematopoietic Stem Cell Transplantation for Adult Metachromatic Leukodystrophy (MLD): A Case Series. Blood Adv. 2024.
Klimentova M, Perminova M, Shelikhova L, Abugova Y, Kobyzeva D, Pershin D, Balashov D, Myakova N, Maschan A, Maschan M. Allogeneic hematopoietic stem cell transplantation for mature T/NK-cell lymphomas in children. Transplant Cell Ther. 2024.

Pages